{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:43:29Z","timestamp":1791981809951,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.nbd.2022.105964","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T20:04:36Z","timestamp":1670961876000},"page":"105964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["TNF and IL6\/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy"],"prefix":"10.1016","volume":"176","author":[{"given":"Teresa","family":"Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Moreno-Estell\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Campos-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2022.105964_bb0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2022.105964_bb0010","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/ijms22041506","article-title":"Regulation, activation and function of caspase-11 during health and disease","volume":"22","author":"Agnew","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2022.105964_bb0015","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/hmg\/ddq190","article-title":"Laforin, the most common protein mutated in Lafora disease, regulates autophagy","volume":"19","author":"Aguado","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2022.105964_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105376","article-title":"The role of tumour necrosis factor in neuroinflammation associated with Parkinson\u2019s disease and targeted therapies","volume":"158","author":"Amin","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2022.105964_bb0025","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s12035-015-9091-8","article-title":"Pharmacological interventions to ameliorate neuropathological symptoms in a mouse model of Lafora disease","volume":"53","author":"Berthier","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105964_bb0030","article-title":"Early treatment with metformin improves neurological outcomes in Lafora disease","author":"Burgos","year":"2022","journal-title":"Neurotherapeutics."},{"key":"10.1016\/j.nbd.2022.105964_bb0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/ars.2020.8076","article-title":"Inflammation in neurological disorders: the thin boundary between brain and periphery","volume":"33","author":"Cervellati","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2022.105964_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ng1238","article-title":"Mutations in NHLRC1 cause progressive myoclonus epilepsy","volume":"35","author":"Chan","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2022.105964_bb0045","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10753-021-01439-6","article-title":"The signaling pathways regulating NLRP3 inflammasome activation","volume":"44","author":"Chen","year":"2021","journal-title":"Inflammation."},{"key":"10.1016\/j.nbd.2022.105964_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/biomedicines6020043","article-title":"The many roles of ubiquitin in NF-kappaB signaling","volume":"6","author":"Courtois","year":"2018","journal-title":"Biomedicines."},{"key":"10.1016\/j.nbd.2022.105964_bb0055","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/hmg\/ddr590","article-title":"Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy","volume":"21","author":"Criado","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2022.105964_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-10-5987-2_1","article-title":"Activation of the innate immune receptors: guardians of the micro galaxy\u202f: activation and functions of the innate immune receptors","volume":"1024","author":"De Nardo","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2022.105964_bb0065","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11910-007-0066-7","article-title":"Advances in lafora progressive myoclonus epilepsy","volume":"7","author":"Delgado-Escueta","year":"2007","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.nbd.2022.105964_bb0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tips.2016.03.001","article-title":"Anti-inflammatory small molecules to treat seizures and epilepsy: from bench to bedside","volume":"37","author":"Dey","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2022.105964_bb0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00381-020-04920-z","article-title":"Circulating glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase-L1 as markers of neuronal damage in children with epileptic seizures","volume":"37","author":"Elhady","year":"2021","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.nbd.2022.105964_bb0080","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","article-title":"Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis","volume":"575","author":"Fritsch","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2022.105964_bb0085","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","article-title":"Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice","volume":"11","author":"Ganesh","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2022.105964_bb0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/NEN.0b013e318253350f","article-title":"Laforin and malin deletions in mice produce similar neurologic impairments","volume":"71","author":"Garcia-Cabrero","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2022.105964_bb0095","first-page":"291","article-title":"Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole","volume":"8","author":"Garcia-Cabrero","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2022.105964_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/cells7080087","article-title":"Lafora disease: a ubiquitination-related pathology","volume":"7","author":"Garcia-Gimeno","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.nbd.2022.105964_bb0105","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.1073\/pnas.0503285102","article-title":"Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin","volume":"102","author":"Gentry","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2022.105964_bb0110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/01.WNL.0000154519.10805.F7","article-title":"Lafora disease due to EPM2B mutations. A clinical and genetic study","volume":"64","author":"G\u00f3mez-Abad","year":"2005","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2022.105964_bb0115","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1007\/s00415-022-11004-2","article-title":"Neuron Specific Enolase, S100-beta protein and progranulin as diagnostic biomarkers of status epilepticus","volume":"269","author":"Hanin","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2022.105964_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108624","article-title":"Serum glial fibrillary acidic protein is a body fluid biomarker: a valuable prognostic for neurological disease - a systematic review","volume":"107","author":"Heimfarth","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.nbd.2022.105964_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.577312","article-title":"Peripheral blood and salivary biomarkers of blood-brain barrier permeability and neuronal damage: clinical and applied concepts","volume":"11","author":"Janigro","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2022.105964_bb0130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kramer","year":"2014","journal-title":"Bioinformatics."},{"key":"10.1016\/j.nbd.2022.105964_bb0135","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/febs.14468","article-title":"Degradation of altered mitochondria by autophagy is impaired in Lafora disease","volume":"285","author":"Lahuerta","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2022.105964_bb0140","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s12035-019-01842-z","article-title":"Reactive glia-derived neuroinflammation: a novel Hallmark in Lafora progressive myoclonus epilepsy that progresses with age","volume":"57","author":"Lahuerta","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105964_bb0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s40495-017-0117-y","article-title":"TRAF molecules in inflammation and inflammatory diseases","volume":"4","author":"Lalani","year":"2018","journal-title":"Curr. Pharmacol. Rep."},{"key":"10.1016\/j.nbd.2022.105964_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105152","article-title":"Gene expression in the epileptic (EL) mouse hippocampus","volume":"147","author":"Lee","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105964_bb0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41573-022-00390-x","article-title":"Function and therapeutic value of astrocytes in neurological diseases","volume":"21","author":"Lee","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2022.105964_bb0160","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","article-title":"Astrocyte crosstalk in CNS inflammation","volume":"108","author":"Linnerbauer","year":"2020","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2022.105964_bb0165","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s12035-016-9884-4","article-title":"Inflammation in Lafora disease: evolution with disease progression in laforin and malin knock-out mouse models","volume":"54","author":"Lopez-Gonzalez","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105964_bb0170","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.3390\/ijms23063284","article-title":"The signaling pathway of TNF receptors: linking animal models of renal disease to human CKD","volume":"23","author":"Lousa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2022.105964_bb0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.expneurol.2012.04.008","article-title":"Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice","volume":"236","author":"Machado-Salas","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2022.105964_bb0180","doi-asserted-by":"crossref","first-page":"31736","DOI":"10.1074\/jbc.M114.609396","article-title":"A role for stefin B (cystatin B) in inflammation and endotoxemia","volume":"289","author":"Maher","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105964_bb0185","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1039\/D1MD00036E","article-title":"Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders","volume":"12","author":"Miller","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.nbd.2022.105964_bb0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/2470","article-title":"Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy","volume":"20","author":"Minassian","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2022.105964_bb0195","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1007\/s12035-021-02285-1","article-title":"Modulators of Neuroinflammation have a beneficial effect in a Lafora disease mouse model","volume":"58","author":"Molla","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105964_bb0200","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1007\/s12035-022-02956-7","article-title":"Pharmacological modulation of glutamatergic and neuroinflammatory pathways in a Lafora disease mouse model","volume":"59","author":"Molla","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105964_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2020.09.015","article-title":"Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: from pathogenesis to treatment target","volume":"82","author":"Mukhtar","year":"2020","journal-title":"Seizure."},{"key":"10.1016\/j.nbd.2022.105964_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2020.12.009","article-title":"Serum biomarkers of cerebral cellular stress after self-limiting tonic clonic seizures: an exploratory study","volume":"85","author":"Nass","year":"2021","journal-title":"Seizure."},{"key":"10.1016\/j.nbd.2022.105964_bb0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-016-0764-7","article-title":"Brain inflammation is accompanied by peripheral inflammation in Cstb (\u2212\/\u2212) mice, a model for progressive myoclonus epilepsy","volume":"13","author":"Okuneva","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2022.105964_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676621","article-title":"Immune response in neurological pathology: emerging role of central and peripheral immune crosstalk","volume":"12","author":"Passaro","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nbd.2022.105964_bb0225","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/glia.23956","article-title":"Endocytosis of the glutamate transporter 1 is regulated by laforin and Malin: implications in Lafora disease","volume":"69","author":"Perez-Jimenez","year":"2021","journal-title":"Glia."},{"key":"10.1016\/j.nbd.2022.105964_bb0230","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s13023-021-01989-w","article-title":"Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis","volume":"16","author":"Pondrelli","year":"2021","journal-title":"Orphan. J. Rare Dis."},{"key":"10.1016\/j.nbd.2022.105964_bb0235","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.4161\/auto.6.8.13307","article-title":"Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?","volume":"6","author":"Puri","year":"2010","journal-title":"Autophagy."},{"key":"10.1016\/j.nbd.2022.105964_bb0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41590-019-0368-3","article-title":"Innate immunity to intracellular LPS","volume":"20","author":"Rathinam","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.nbd.2022.105964_bb0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/epi4.12242","article-title":"Pharmacological targeting of brain inflammation in epilepsy: therapeutic perspectives from experimental and clinical studies","volume":"3","author":"Ravizza","year":"2018","journal-title":"Epilepsia Open."},{"key":"10.1016\/j.nbd.2022.105964_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.618193","article-title":"Corpora amylacea in the human brain exhibit neoepitopes of a carbohydrate nature","volume":"12","author":"Riba","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nbd.2022.105964_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113203","article-title":"Necroptosis in Alzheimer\u2019s disease: potential therapeutic target","volume":"152","author":"Richard","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.nbd.2022.105964_bb0260","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1038\/s41598-020-63766-2","article-title":"Innate immune functions of astrocytes are dependent upon tumor necrosis factor-alpha","volume":"10","author":"Rodgers","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2022.105964_bb0265","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.freeradbiomed.2015.01.034","article-title":"Oxidative stress, a new hallmark in the pathophysiology of Lafora progressive myoclonus epilepsy","volume":"88","author":"Roma-Mateo","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2022.105964_bb0270","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/hmg\/ddy044","article-title":"Astrocytes: new players in progressive myoclonus epilepsy of Lafora type","volume":"27","author":"Rubio-Villena","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2022.105964_bb0275","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3389\/fimmu.2018.01849","article-title":"Tumor necrosis factor receptor-associated factor regulation of nuclear factor kappaB and mitogen-activated protein kinase pathways","volume":"9","author":"Shi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nbd.2022.105964_bb0280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41582-021-00461-4","article-title":"Identification of clinically relevant biomarkers of epileptogenesis - a strategic roadmap","volume":"17","author":"Simonato","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2022.105964_bb0285","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/hmg\/ddm339","article-title":"Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway","volume":"17","author":"Solaz-Fuster","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"1404\u20131417","key":"10.1016\/j.nbd.2022.105964_bb0290","article-title":"Brain glycogen serves as a critical glucosamine cache required for protein glycosylation","volume":"33","author":"Sun","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2022.105964_bb0295","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.2174\/1381612823666170926113754","article-title":"Inflammation and epilepsy: preclinical findings and potential clinical translation","volume":"23","author":"Terrone","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2022.105964_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.04.028","article-title":"Inflammation and reactive oxygen species in status epilepticus: biomarkers and implications for therapy","volume":"101","author":"Terrone","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.nbd.2022.105964_bb0305","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/epi.16914","article-title":"T cell numbers correlate with neuronal loss rather than with seizure activity in medial temporal lobe epilepsy","volume":"62","author":"Troscher","year":"2021","journal-title":"Epilepsia."},{"key":"10.1016\/j.nbd.2022.105964_bb0310","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1684\/epd.2016.0842","article-title":"Lafora disease","volume":"18","author":"Turnbull","year":"2016","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.nbd.2022.105964_bb0315","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.3390\/ijms22094395","article-title":"Links between immune cells from the periphery and the brain in the pathogenesis of epilepsy: a narrative review","volume":"22","author":"Yamanaka","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122003564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122003564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:39:19Z","timestamp":1760852359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996122003564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":63,"alternative-id":["S0969996122003564"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105964","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF and IL6\/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105964"}}